Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Starts Presentation at 29th Annual ROTH Conference
IntelliPharmaCeutics International (NASDAQ: IPCI) is a pharmaceutical company that engages in the research, development, and manufacture of novel and generic controlled and targeted release oral solid dosage drugs. The company develops various drug delivery systems and a pipeline of products based on its patented Hypermatrix technology in various stages of development in therapeutic areas, such … Continue reading “Intellipharmaceutics International, Inc. (NASDAQ: IPCI) Starts Presentation at 29th Annual ROTH Conference”







